These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 29033569)
1. Associations among depression severity, painful physical symptoms, and social and occupational functioning impairment in patients with major depressive disorder: a 3-month, prospective, observational study. Harada E; Satoi Y; Kuga A; Tokuoka H; Kikuchi T; Watanabe K; Alev L; Mimura M Neuropsychiatr Dis Treat; 2017; 13():2437-2445. PubMed ID: 29033569 [TBL] [Abstract][Full Text] [Related]
2. Residual symptoms in patients with partial versus complete remission of a major depressive disorder episode: patterns of painful physical symptoms in depression. Harada E; Satoi Y; Kikuchi T; Watanabe K; Alev L; Mimura M Neuropsychiatr Dis Treat; 2016; 12():1599-607. PubMed ID: 27418827 [TBL] [Abstract][Full Text] [Related]
3. Social and occupational functioning impairment in patients in partial versus complete remission of a major depressive disorder episode. A six-month prospective epidemiological study. Romera I; Perez V; Menchón JM; Delgado-Cohen H; Polavieja P; Gilaberte I Eur Psychiatry; 2010 Jan; 25(1):58-65. PubMed ID: 19553092 [TBL] [Abstract][Full Text] [Related]
4. An observational study of duloxetine versus SSRI monotherapy in Japanese patients with major depressive disorder: subgroup analyses of treatment effectiveness for pain, depressive symptoms, and quality of life. Kuga A; Tsuji T; Hayashi S; Fujikoshi S; Tokuoka H; Yoshikawa A; Escobar R; Tanaka K; Azekawa T Neuropsychiatr Dis Treat; 2017; 13():2115-2124. PubMed ID: 28831260 [TBL] [Abstract][Full Text] [Related]
5. Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapy. Kuga A; Otsubo T; Tsuji T; Hayashi S; Imagawa H; Fujikoshi S; Escobar R Neuropsychiatr Dis Treat; 2019; 15():809-817. PubMed ID: 31040680 [TBL] [Abstract][Full Text] [Related]
6. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine. Ninan PT; Shelton RC; Bao W; Guico-Pabia CJ Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():86-91. PubMed ID: 24096053 [TBL] [Abstract][Full Text] [Related]
7. Novel Augmentation Strategies in Major Depression. Martiny K Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173 [TBL] [Abstract][Full Text] [Related]
8. Predicting treatment outcomes of major depressive disorder by early improvement in painful physical symptoms: a pooled analysis of double-blind, placebo-controlled trials of duloxetine. Tokuoka H; Nishihara M; Fujikoshi S; Yoshikawa A; Kuga A Neuropsychiatr Dis Treat; 2017; 13():2457-2467. PubMed ID: 29026309 [TBL] [Abstract][Full Text] [Related]
9. Duloxetine versus placebo in the treatment of major depressive disorder and associated painful physical symptoms: a replication study. Gaynor PJ; Gopal M; Zheng W; Martinez JM; Robinson MJ; Hann D; Marangell LB Curr Med Res Opin; 2011 Oct; 27(10):1859-67. PubMed ID: 21838410 [TBL] [Abstract][Full Text] [Related]
10. Re-evaluation of the definition of remission on the 17-item Hamilton Depression Rating Scale based on recovery in health-related quality of life in an observational post-marketing study. Sawamura J; Ishigooka J; Nishimura K Health Qual Life Outcomes; 2018 Jan; 16(1):14. PubMed ID: 29338728 [TBL] [Abstract][Full Text] [Related]
11. A meta-analysis of the efficacy of venlafaxine extended release 75-225 mg/day for the treatment of major depressive disorder. Thase M; Asami Y; Wajsbrot D; Dorries K; Boucher M; Pappadopulos E Curr Med Res Opin; 2017 Feb; 33(2):317-326. PubMed ID: 27794623 [TBL] [Abstract][Full Text] [Related]
12. Frequency of painful physical symptoms with major depressive disorder in asia: relationship with disease severity and quality of life. Lee P; Zhang M; Hong JP; Chua HC; Chen KP; Tang SW; Chan BT; Lee MS; Lee B; Gallagher GL; Dossenbach M J Clin Psychiatry; 2009 Jan; 70(1):83-91. PubMed ID: 19192462 [TBL] [Abstract][Full Text] [Related]
13. A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical symptoms. Gaynor PJ; Gopal M; Zheng W; Martinez JM; Robinson MJ; Marangell LB Curr Med Res Opin; 2011 Oct; 27(10):1849-58. PubMed ID: 21838411 [TBL] [Abstract][Full Text] [Related]
14. An observational study of duloxetine versus SSRI monotherapy for the treatment of painful physical symptoms in Japanese patients with major depressive disorder: primary analysis. Kuga A; Tsuji T; Hayashi S; Matsubara M; Fujikoshi S; Tokuoka H; Yoshikawa A; Escobar R; Tanaka K; Azekawa T Neuropsychiatr Dis Treat; 2017; 13():2105-2114. PubMed ID: 28831259 [TBL] [Abstract][Full Text] [Related]
15. Relief of depression and pain improves daily functioning and quality of life in patients with major depressive disorder. Lin CH; Yen YC; Chen MC; Chen CC Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():93-8. PubMed ID: 23989033 [TBL] [Abstract][Full Text] [Related]
16. Relationship between major depressive disorder and associated painful physical symptoms: analysis of data from two pooled placebo-controlled, randomized studies of duloxetine. Robinson MJ; Sheehan D; Gaynor PJ; Marangell LB; Tanaka Y; Lipsius S; Ohara F; Namiki C Int Clin Psychopharmacol; 2013 Nov; 28(6):330-8. PubMed ID: 23873291 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of antidepressants in the treatment of major depressive disorder in Latin America. Dueñas HJ; Dwight T; McBride ME; Brnabic AJ; Semper LA; Holmgren D; Miranda-Scippa AM; Rincón HG; Aguilera H; Vargas A Int J Psychiatry Clin Pract; 2007; 11(2):129-39. PubMed ID: 24937558 [TBL] [Abstract][Full Text] [Related]
18. Association between painful physical symptoms and clinical outcomes in East Asian patients with major depressive disorder: a 3-month prospective observational study. Ang QQ; Wing YK; He Y; Sulaiman AH; Chiu NY; Shen YC; Wang G; Zhang C; Lee KH; Singh P; Granger RE; Raskin J; Dossenbach M Int J Clin Pract; 2009 Jul; 63(7):1041-9. PubMed ID: 19570122 [TBL] [Abstract][Full Text] [Related]
19. Major depressive disorder severity and the frequency of painful physical symptoms: a pooled analysis of observational studies. Brnabic A; Lin C; Monkul ES; Dueñas H; Raskin J Curr Med Res Opin; 2012 Dec; 28(12):1891-7. PubMed ID: 23145858 [TBL] [Abstract][Full Text] [Related]
20. Functional impairment in patients with major depression in clinical remission: results from the VIVAL-D-Rem, a nationwide, naturalistic, cross-sectional survey. Sacchetti E; Frank E; Siracusano A; Racagni G; Vita A; Turrina C Int Clin Psychopharmacol; 2015 May; 30(3):129-41. PubMed ID: 25828864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]